ThreePointCircle
Bluelighter
- Joined
- Apr 21, 2016
- Messages
- 378
Could you ask them whether they are capable of doing some sensitive tests for the presence of low-concentration OH groups in the sample ?
Following suggestions on here, I asked them for the following:
...
Known inhibitors:
MDDMA [1,2]
MDTMA [2]
1,3-bis (3,4-methylenedioxyphenyl)-2-propanamine [3,4]
N-formyl-1,3-bis (3,4-methylenedioxyphenyl)-prop-2-yl-amine [3,4]
Also particularly interested in M-ALPHA-HMCA [5]
Additionally: bk-MDMA, MDE, ethylone, butylone, 6-MAPB, n-methyl-MDDMA, 3,4-dimethoxyamphetamine and 3,4-dimethoxy-n-methyl-amphetamine, and in general all the regioisomers of MDMA?
Also, 3-MMC, 4-MMC, 5-APB, 5-MAPB, 6-APB, but I see you already listed these.
And some were keen to see NMR, GC/MS MALDI, RAMEN results and anything else that can be thrown at it.
I know I'm asking for a lot so appreciate all that you can do.
Refs:
[1] Optimization of HS-SPME/GC–MS analysis and its use in the profiling of illicit ecstasy tablets (Part 1), Forensic Science International 187 (2009) 73–80
[2] Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine Transporters, Mol Pharmacol. 2016 Jan; 89(1): 165–175
[3] Pharmacological Characterization of Ecstasy Synthesis Byproducts with Recombinant Human Monoamine Transporters, JPET 314:346–354, 2005
[4] Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine Int J Leg Med (1993) 106: 19-23
[5] Identification of a new M-ALPHA analog and MDMA in an illegal health product, Forensic Science International, 313 (2020)
....
They just said, yeah we can do that. In retrospect it wasn't the kind of response that makes me feel asking for any more detail would get us anywhere.
